Single nucleotide polymorphisms in the DMBT1 promoter and the progression of breast cancer [2]

International Journal of Cancer

Volumn 120, Issue 2, 2007, Pages 447-449

  Lei, Haixin ^a   Hemminki, Kari ^a,b   Johansson, Robert ^c   Altieri, Andrea ^a   Enquist, Kerstin ^d   Henriksson, Roger ^c   Lenner, Per ^c   Försti, Asta ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^d UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER GROWTH; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DMBT1 GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC SCREENING; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; DISEASE PROGRESSION; ESTROGENS; FEMALE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGESTERONE; PROMOTER REGIONS (GENETICS); RECEPTORS, CELL SURFACE; RESPONSE ELEMENTS; SWEDEN;

EID: 33845622039     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22182     Document Type: Letter

References (10)

1. Mollenhauer J, Wiemann S, Scheurlen W, Korn B, Hayashi Y, Wilgenbus KK, von Deimling A, Poustka A. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours. Nat Genet 1997;17:32-9.
2. Braidotti P, Nuciforo PG, Mollenhauer J, Pouslka A, Pellegrini C, Moro A, Bulfamante G, Coggi G, Bosari S, Pietra GG. DMBT1 expression is down-regulated in breast cancer. BMC Cancer 2004;4:46.
3. Mollenhauer J, Helmke B, Medina D, Bergmann G, Gassler N, Muller H, Lyer S, Diedrichs L, Renner M, Wittig R, Blaich S, Hamann U, et al. Carcinogen inducibility in vivo and down-regulation of DMBT1 during breast carcinogenesis. Genes Chromosomes Cancer 2004;39:185-94.
4. Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006;354:270-82.
5. Ismail PM, Amato P, Soyal SM, DeMayo FJ, Conneely OM, O'Malley BW, Lydon JP. Progesterone involvement in breast development and tumorigenesis-as revealed by progesterone receptor "knockout" and "knockin" mouse models. Steroids 2003;68:779-87.
6. Soyal S, Ismail PM, Li J, Mulac-Jericevic B, Conneely OM, Lydon JP. Progesterone's role in mammary gland development and tumorigenesis as disclosed by experimental mouse genetics. Breast Cancer Res 2002;4:191-6.
7. Tynan S, Pacia E, Haynes-Johnson D, Lawrence D, D'Andrea MR, Guo JZ, Lundeen S, Allan G. The putative tumor suppressor deleted in malignant brain tumors 1 is an estrogen-regulated gene in rodent and primate endometrial epithelium. Endocrinology 2005;146:1066-73.
8. Ace CI, Okulicz WC. A progesterone-induced endometrial homolog of a new candidate tumor suppressor. DMBT1. J Clin Endocrinol Metab 1998;83:3569-73.
9. Ace CI, Okulicz WC. The 5́ Hanking region of the Rhesus monkey H3 (DMBT1) gene contains putative progesterone response elements. DNA Cell Biol 2005;24:345-9.
10. Jin Q, Hemminki K, Enquist K, Lenner P, Grzybowska E, Klaes R, Henriksson R, Chen B, Pamulla J, Pekala W, Zientek H, Rogozinska-Szezepka J. et al. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res 2005;11:3647-53.